$RXMD new deal represents significantly improved
Post# of 23604
As noted in the release, on November 8, 2019, the company entered into an amended version of its Stock Purchase Agreement with the Seller, pursuant to which the company has agreed to modified terms and an adjusted purchase price of $1,900,000 for 100% of the issued and outstanding shares of common stock of the Seller. That’s about $1.1 million less than the original agreement – a drop of about 36% in total acquisition cost.
Another plus in this renegotiation is that the company has already put $2.3 million into escrow to handle the transaction, a million of which has already been transferred to the seller. https://dailytrendingstocks.com/why-progressi...s-morning/